Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market sheeba farhat5 Jan 2026 6:19 PM ISTThe Wegovy pill ​could attract new consumers as Novo looks to revive ​its fortunes after profit warnings and sliding shares in 2025.
Price war in China weight loss market: Novo Nordisk, Eli Lilly slash prices of Wegovy, Mounjaro Ruchika Sharma30 Dec 2025 6:08 PM ISTGlobal drugmakers Novo Nordisk and Eli Lilly have kicked off a price battle in China’s obesity treatment market, cutting prices of their blockbuster...
Eli Lilly, Novo Nordisk race to lock in India obesity drug market Ruchika Sharma26 Dec 2025 4:23 PM ISTHyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming obesity drug market,...
Pill form of Wegovy gets USFDA approval for weight loss Ruchika Sharma23 Dec 2025 1:30 PM IST Plainsboro: In a major development, Novo Nordisk has received approval from the US Food and Drug Administration (FDA) for popular GLP-1...
Novo Nordisk Gets CDSCO Panel Nod to Update Wegovy Label With New Safety, Pharmacodynamics Data Susmita Roy14 Dec 2025 12:43 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo...
Sun Pharma Agrees to Halt India Sales of Semaglutide After Delhi HC Records Patent Undertaking Susmita Roy11 Dec 2025 4:08 PM ISTNew Delhi: The Delhi High Court on Wednesday recorded a categorical undertaking from Sun Pharma that it will not market or sell its semaglutide...
Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac Susmita Roy10 Dec 2025 5:37 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) recorded a steady rise in November 2025, growing 9.06% month-on-month (MoM) in value, even as unit...
Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to Continue Susmita Roy5 Dec 2025 10:28 PM ISTNew Delhi: In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused...
Tradipitant may Reduce Semaglutide-Induced Nausea and Vomiting, reports research Dr. Kamal Kant Kohli21 Nov 2025 8:00 PM ISTIn a randomized trial of adults with obesity or overweight, Vanda Pharmaceuticals' investigational NK-1 receptor antagonist tradipitant significantly...
Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales Farhat Nasim10 Oct 2025 3:46 PM ISTNew Delhi: In a remarkable rise, Eli Lilly's Mounjaro (tirzepatide) has become India's second-highest selling drug by value within just six months of...
Gates Foundation, PAHO Push to Make Mounjaro, Wegovy Affordable in Low-Income Countries MD Bureau10 Oct 2025 3:15 PM ISTNew Delhi: The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo Nordisk's Wegovy...
Novo Nordisk's Wegovy, Fiasp, Ryzodeg Injectables Stolen During Transit, DCGI Issues Alert Susmita Roy23 Aug 2025 3:00 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has issued an alert for doctors and healthcare professionals to carefully prescribe and...
